Angelo Velle
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial.
Journal: ESMO open
Published: October 03, 2025
Givinostat inhibits in vitro differentiation of cardiac fibroadipogenic precursors from a mouse model of arrhythmogenic cardiomyopathy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 30, 2025
HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib.
Journal: ESMO open
Published: September 12, 2024
BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.
Journal: Science advances
Published: September 04, 2024
Publisher Correction: Interactomic exploration of LRRC8A in volume-regulated anion channels.
Journal: Cell death discovery
Published: August 29, 2024
Interactomic exploration of LRRC8A in volume-regulated anion channels.
Journal: Cell death discovery
Published: November 27, 2023
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma.
Journal: Cell death & disease
Published: July 12, 2023
A comprehensive investigation of histotype-specific microRNA and their variants in Stage I epithelial ovarian cancers.
Journal: International journal of cancer
Published: September 26, 2022
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 03, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026